Johan from Denmark

Registered at the short selling broker Capital, 3 minutes ago.

» Try Capital you too
75% of retail investor accounts lose money when trading CFDs with Capital.
Don't show again

CARA Therapeutics, Inc. (CARA) shares information

Cara Therapeutics Inc


24h Change

-2.39 %

CARA

Live rate: Market closed

Stock data per Tuesday 26 Jan, 2021

CARA
NASDAQ/NMS (GLOBAL MARKET)
19.65
19.68
19.18
-0.47 (-2.39%)
US Market is closed

Live Stock price in graph for Cara Therapeutics Inc (CARA)

  • Latest Volume

    269,474 (-64.29 %)

  • Volume prev. day

    754,680

  • Avg. daily volume

    503,661

  • Market cap

    955,779,755

  • P/E ratio

    -9.05

  • Today high

    n/a

  • Today low

    n/a

  • 52 week high

    20.26 USD

  • 52 week low

    9.12 USD

  • YTD Change

    + 24.38 %

Quick links

 

Latest news about Cara Therapeutics Inc

Below you can find the most recent news posts about Cara Therapeutics Inc, primarily from US and UK based news sources.

Cannabis Stock Gainers And Losers From January 25, 2021

Monday, 25 January 2021, 22:41:25
GAINERS: Primo Nutraceuticals (PINK: BUGVF ) shares closed up 80% at $0.90 MGC Pharmaceuticals (PINK: MGCLF ) shares closed up 55% at $0.03 High Tide (OTCQB: HITIF ) shares closed up 21.77% at $0.47 BioHarvest Sciences (OTC: CNVCF) shares closed up 17.33% at $0.47 Helix Technologies (OTCQB: HLIX ) shares closed up 10.94% at $0.71 Cannabix Technologies (PINK: BLOZF ) shares closed up 8.39% at $1.28 CURE Pharmaceutical Hldg (OTCQB: CURR ) shares closed up 6.06% at $1.40 Cara Therapeutics (NASDAQ: CARA ) shares closed up 2.61% at $19.65 LOSERS: iAnthus Capital Hldgs (PINK: ITHUF ) shares closed down 30.98% at $0.29 Full story available on Benzinga.com
— Benzinga


Cara Therapeutics, Inc. (NASDAQ:CARA) CEO Derek T. Chalmers Sells 6,078 Shares

Saturday, 2 January 2021, 11:32:41
Cara Therapeutics, Inc. (NASDAQ:CARA) CEO Derek T. Chalmers sold 6,078 shares of the business’s stock in a transaction that occurred on Wednesday, December 30th. The stock was sold at an average price of $15.30, for a total value of $92,993.40. Following the sale, the chief executive officer now owns 936,593 shares of the company’s stock, […]
— Watchlist News


Stamford-based Cara Therapeutics seeks FDA approval for drug for kidney-disease patients

Monday, 28 December 2020, 20:00:00
If the FDA approves Cara Therapeutics’ application, its Korsuva injection would be the Stamford-based company’s first treatment to go on the market.
— CT Insider


Derek T. Chalmers Sells 7,500 Shares of Cara Therapeutics, Inc. (NASDAQ:CARA) Stock

Monday, 14 December 2020, 11:40:42
Cara Therapeutics, Inc. (NASDAQ:CARA) CEO Derek T. Chalmers sold 7,500 shares of the business’s stock in a transaction on Thursday, December 10th. The stock was sold at an average price of $15.29, for a total transaction of $114,675.00. Following the transaction, the chief executive officer now owns 933,921 shares in the company, valued at $14,279,652.09. […]
— Watchlist News


Asia Pacific Medical Marijuana Market Assessments Report 2020 | Cannabis Sativa, Cara Therapeutics, CannaGrow Holdings, Growbox Sciences, United Cannabis, GreenGro Technologies, Lxaria Crop

Monday, 23 November 2020, 18:02:23
Medical marijuana is a type of drug that is used to treat a number of medical conditions such as chronic pain, Alzheimer’s, depression, nausea, cancer, and epilepsy. Since marijuana is a highly addictive drug, governments of several countries have enforced
— OpenPR


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €200
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have CARA available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.